Muriel Duluc
Impact in
-
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 9
- Colorectal Cancer Treatments and Studies 6
- Pancreatic and Hepatic Oncology Research 5
- Peptidase Inhibition and Analysis 1
-
- Neuroendocrine Tumor Research Advances 3
- Co-authors
- Laëtitia Dahan (8 shared papers)Jean‐François Seitz (6 shared papers)Joseph Ciccolini (5 shared papers)Bruno Lacarelle (2 shared papers)Cédric Mercier (3 shared papers)Caroline Raynal (2 shared papers)Aurore Blesius (2 shared papers)Alexandre Evrard (3 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Annals of Oncology (2 papers)Pharmacogenomics (1 paper)British Journal of Clinical Pharmacology (1 paper)Pharmacogenetics and Genomics (1 paper)
- Partner nations
- France
In The Last Decade
Muriel Duluc
10 papers receiving 223 citations
Peers
Comparison fields: 5 of 42
- Oncology 147
- Transplantation 8
- Cancer Research 40
- Genetics 28
- Hematology 22
Countries citing papers authored by Muriel Duluc
This map shows the geographic impact of Muriel Duluc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muriel Duluc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muriel Duluc more than expected).
Fields of papers citing papers by Muriel Duluc
This network shows the impact of papers produced by Muriel Duluc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muriel Duluc. The network helps show where Muriel Duluc may publish in the future.
Co-authors
The 25 scholars most cited alongside Muriel Duluc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 86 | |
| 2 | 2007 | 43 | |
| 3 | 2015 | 43 | |
| 4 | 2013 | 33 | |
| 5 | 2013 | 8 | |
| 6 | 2007 | 5 | |
| 7 | 2016 | 3 | |
| 8 | 2018 | 2 | |
| 9 | 2021 | 1 | |
| 10 | 2010 | 1 | |
| 11 | REVIEW OF IRSN WORK REGARDING NUCLEAR CRITICALITY ACCIDENT | 2019 | 0 |
About Muriel Duluc
Muriel Duluc is a scholar working on Oncology, Epidemiology, Cancer Research, Genetics and Molecular Biology, having authored 11 papers that have together received 225 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (6 papers), Pancreatic and Hepatic Oncology Research (5 papers), Cancer Genomics and Diagnostics (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Nuclear and radioactivity studies (1 paper), Hepatocellular Carcinoma Treatment and Prognosis (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Oncology (147 citations), Transplantation (8 citations), Cancer Research (40 citations), Genetics (28 citations) and Hematology (22 citations). Muriel Duluc has collaborated with scholars based in France. Frequent co-authors include Laëtitia Dahan, Jean‐François Seitz, Joseph Ciccolini, Bruno Lacarelle, Cédric Mercier, Caroline Raynal, Aurore Blesius, Alexandre Evrard, G. Milano and Sarah Giacometti. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Pharmacogenomics, British Journal of Clinical Pharmacology and Pharmacogenetics and Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.